Development of novel ACN (albumin, C-reactive protein and neutrophil-to-lymphocyte ratio) prognostication model for patients with metastatic renal cell carcinoma receiving first-line molecular-targeted therapy-Reference-Cited by-同舟云学术

Development of novel ACN (albumin, C-reactive protein and neutrophil-to-lymphocyte ratio) prognostication model for patients with metastatic renal cell carcinoma receiving first-line molecular-targeted therapy

Published:2021-01 Issue:1 Volume:39 Page:78.e1-78.e8
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Tamura Keita,Ando Ryosuke,Takahara Kiyoshi,Ito Toshiki,Kanao Kent,Yasui Takahiro,Shiroki Ryoichi,Miyake Hideaki

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. Systemic therapy in metastatic renal cell carcinoma;Bedke;World J Urol,2017

2. Immune checkpoint inhibitors: toward new paradigms in renal cell carcinoma;Flippot;Drugs,2018

3. What is the optimal therapy for patients with metastatic renal cell carcinoma who progress on an initial VEGFr-TKI?;Calvo;Cancer Treat Rev,2013

4. Prognostic factors and prognostic models for renal cell carcinoma: a literature review;Klatte;World J Urol,2018

5. Early tumor shrinkage under treatment with first-line tyrosine kinase inhibitors as a predictor of overall survival in patients with metastatic renal cell carcinoma: a rtrospective multi-institutional study in Japan;Miyake;Target Oncol,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Prognostic Variables for Overall Survival in Patients with Metastatic Renal Cell Carcinoma: A Meta-Analysis Of 29,366 Patients;JU Open Plus;2024-04

2. VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas;Cellular Oncology;2022-07-14

3. Long-term outcome of renal cell carcinoma in patients with HIV who undergo surgery;BMC Infectious Diseases;2022-07-09

4. Comprehensive assessments of immuno‐oncology drug‐based combination therapies as first‐line treatment for advanced renal cell carcinoma;International Journal of Urology;2022-05-30

5. Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer;Japanese Journal of Clinical Oncology;2022-04-23